CLINICAL RATING SCALES
Standardized ADHD rating scales can streamline diagnosis1-3
Input from rating scales can help clinicians more quickly identify ADHD—a condition that is underdiagnosed in adult patients1-3
Clinical Rating Scales
Clinical rating scales can enhance ADHD assessments
- Screening tools help create a complete clinical picture, minimizing the potential for an incorrect diagnosis or missed comorbidities1,3
ADHD RATING SCALES AVAILABLE FOR USE WITH ADULTS
An 18-item scale comprised of items that correspond directly to DSM-5 symptoms of ADHD.
Although originally designed for use in a pediatric population, this instrument has been modified to include prompts specific to adult ADHD symptoms.
- 9 items assessing hyperactivity
- 9 items assessing inattention
- Difficulty with concentration
- Difficulty with relaxing/unwinding
- Intrusive behavior
- Inability to complete tasks
A 66-item scale completed by patients; respondents rate their impairment across a number of domains clinically relevant to ADHD (self-report).
- Inattention/memory issues
- Issues with self-concept
- Impulsivity/emotional lability
- Use of rating scales promotes accurate and timely diagnosis in the adult ADHD population, where the disorder is frequently underdiagnosed1-3
- ADHD rating scales can provide a rapid view across different symptoms domains1,5,6
- Jain R, Jain S, Montano B. Addressing diagnosis and treatment gaps in adults with attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord. 2017;19(5):17nr02153. doi: 10.4088/PCC.17nr02153.
- Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019;56:14-34.
- Ramsay JR. Assessment and monitoring of treatment response in adult ADHD patients: current perspectives. Neuropsychiatr Dis Treat. 2017;13:221–232.
- Nasser A, Kosheleff AR, Hull JT, et al. Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness scores into clinical global impressions clinical significance levels in four randomized clinical trials of SPN-812 (viloxazine extended-release) in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adol Psychopharmacology. 2021;31(3):214-226.
- Ustun B, Adler LA, Rudin C, Faraone SV, Spencer TJ, Berglund P, Gruber MJ, Kessler RC. Adult ADHD Self-Report Screening Scale for DSM-5 (ASRS-5). JAMA Psychiatry. 2017;74(5):520-527.
- Connors CK, Erhardt D, Sparrow E. Conners’ Adult ADHD Rating Scales—Self-Report: Long Version (CAAARS—S:L). 2002. Accessed April 24, 2021. https://documents.acer.org/caars-self-l-int1.pdf.